发明名称 Vascularization inhibitors
摘要 <p>This invention provides a therapeutic agent for inhibiting neovascularization, a therapeutic agent for a solid cancer, a therapeutic agent for a disease pathologically caused by neovascularization, and a therapeutic agent for repairing a tissue comprising as the effective ingredient, a substance that potentiates the action of CXCR4. Based on the finding that vascularization is suppressed in CXCR4 knockout mice, it becomes possible to prepare a therapeutic agent for suppressing vascularization, a therapeutic agent for a solid cancer, a therapeutic agent for a disease pathologically caused by neovascularization, each of which comprises as the effective ingredient, a substance that inhibits the action of CXCR4, as well as to prepare a therapeutic agent for repairing a tissue comprising as the effective ingredient, a substance that potentiates the action of CXCR4. By using these substances, treatments are made possible.</p>
申请公布号 EP1745797(A2) 申请公布日期 2007.01.24
申请号 EP20060013016 申请日期 1999.03.23
申请人 CHUGAI SEIYAKU KABUSHIKI KAISHA;KISHIMOTO, TADAMITSU 发明人 KISHIMOTO, TADAMITSU;NAGASAWA, TAKASHI;TACHIBANA, KAZUNOBU
分类号 A61K45/00;A61K31/56;A61K31/70;A61K35/00;A61K38/17;A61K38/43;A61K39/395;A61K48/00;A61P35/00 主分类号 A61K45/00
代理机构 代理人
主权项
地址